ADMA.NASDAQAdma Biologics, INC

Form 4: ADMA Biologics COO Reports Tax Withholding Share Transaction

Sentiment:

SEC Form 4 Filing

📋All filings for Adma Biologics, INC
🔒Login to Follow

Kaitlin M. Kestenberg-Messina, COO and SVP, Compliance of ADMA Biologics, reports the withholding of shares to cover tax obligations upon vesting of restricted stock units.

Summary

  • On September 30, 2024, Kaitlin M. Kestenberg-Messina, COO and SVP, Compliance of ADMA Biologics, had 2,647 shares of common stock withheld by the issuer to satisfy mandatory tax withholding requirements upon the vesting of restricted stock units (RSUs).
  • This was not an open market sale.
  • Following the transaction, Kestenberg-Messina beneficially owns 446,441 shares of ADMA Biologics.
  • This total includes unvested RSUs granted on various dates between February 25, 2021, and April 1, 2024, which vest in quarterly installments, and 129,121 shares of common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing an insider transaction for tax purposes, indicating a neutral sentiment.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, which are common for executives receiving stock-based compensation. It provides transparency into the holdings of company insiders.

Stakeholder Impact

  • The transaction has a minimal impact on shareholders as it is a routine tax withholding and not an open market sale.

Key Dates

DateDescription
02/25/2021Grant date of 5,000 unvested RSUs.
09/28/2021Grant date of 6,250 unvested RSUs.
03/07/2022Grant date of 20,000 unvested RSUs.
03/06/2023Grant date of 71,250 unvested RSUs.
07/24/2023Grant date of 22,500 unvested RSUs.
04/01/2024Grant date of 192,320 unvested RSUs.
09/30/2024Transaction date: 2,647 shares withheld for tax obligations.
10/02/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.